Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Women With IBS-C”

9 trials

Showing 9 of 9 results

Large-scale testing (Phase 3)Study completedNCT00268879
What this trial is testing

Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)

Who this might be right for
Irritable Bowel Syndrome
Alizyme 1,821
Large-scale testing (Phase 3)UnknownNCT00547469
What this trial is testing

The Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Who this might be right for
Irritable Bowel Syndrome
Dynogen Pharmaceuticals 360
Not applicableNo Longer AvailableNCT00511771
What this trial is testing

A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation

Who this might be right for
Irritable Bowel Syndrome With ConstipationChronic Idiopathic Constipation
Novartis
Not applicableStudy completedNCT01097993
What this trial is testing

A Single-centre, Randomised, Double-blind, Controlled, Parallel-group Study to Evaluate the Effect of a Fermented Dairy Product on Abdominal Distension, Digestive Symptoms and Rectal Sensitivity in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Who this might be right for
Women With IBS-C
Danone Global Research & Innovation Center 120
Post-approval studies (Phase 4)Study completedNCT00142987
What this trial is testing

Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS

Who this might be right for
IBS-C and IBS With Mixed Bowel Habits
Novartis 664
Not applicableStudy completedNCT01085643
What this trial is testing

Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)

Who this might be right for
Constipation-predominant Irritable Bowel Syndrome
Cedars-Sinai Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT01056107
What this trial is testing

Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients

Who this might be right for
Irritable Bowel Syndrome Constipation Predominant
Mayo Clinic 52
Large-scale testing (Phase 3)Ended earlyNCT00171431
What this trial is testing

The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)

Who this might be right for
Constipation PredominantIrritable Bowel Syndrome (IBS-C)
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Ended earlyNCT00607971
What this trial is testing

Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Who this might be right for
Constipation-Predominant Irritable Bowel Syndrome
Alizyme 939

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation